SCHEMBL2269075

SCHEMBL2269075

COC(=O)c1ccc(Oc2cccc(Cl)c2)cc1NC(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.56
PYGM P11217 2/20 0.55
PYGL P06737 1/20 0.55
KDM4E B2RXH2 3/20 0.54
HSD17B10 Q99714 2/20 0.54
MAPK1 P28482 1/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
PKM P14618 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
PGR P06401 1/20 0.52
MAPT P10636 2/20 0.51
ALDH1A1 P00352 3/20 0.51
HPGD P15428 3/20 0.51
NPC1 O15118 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GLA P06280 1/20 0.49
GAA P10253 1/20 0.49
ATM Q13315 1/20 0.49
HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2274838 0.89 SERPINE1 (0.66) SERPINE1PYGMPYGLMEN1KMT2A
SCHEMBL2270287 0.83 PYGM (0.70) SERPINE1PYGMPYGLMEN1KMT2A
SCHEMBL2269238 0.82 KDM4E (0.68) KDM4EHSD17B10MAPK1MEN1KMT2A
SCHEMBL14429564 0.82 SERPINE1 (0.54) SERPINE1PYGMPYGLPGRNPC1
SCHEMBL417055 0.81 SERPINE1 (0.80) SERPINE1KDM4EHSD17B10MAPK1MEN1
SCHEMBL2273110 0.81 SERPINE1 (0.60) SERPINE1PYGMPYGLMEN1KMT2A
SCHEMBL2272040 0.80 PGR (0.69) PYGMPYGLMEN1KMT2APKM
SCHEMBL2272347 0.79 SERPINE1 (0.69) SERPINE1PYGMPYGLMEN1KMT2A
SCHEMBL6431592 0.79 PYGM (0.77) PYGMPYGLKDM4EMEN1KMT2A
SCHEMBL2274026 0.79 PGR (0.61) PYGMKDM4EHSD17B10MAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
CN-101094829-A Novel anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO LTD (JP) 2007-12-26 CN disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 SERPINE1 101/4885PYGM 1299/4885PYGL 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.